These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23364341)

  • 1. Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation.
    Zouein FA; Zgheib C; Hamza S; Fuseler JW; Hall JE; Soljancic A; Lopez-Ruiz A; Kurdi M; Booz GW
    Hypertens Res; 2013 Jun; 36(6):496-503. PubMed ID: 23364341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
    Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liu Y; Leung P; Dai X; Yang XP; Peterson EL; Carretero OA
    J Hypertens; 2015 Jan; 33(1):144-52. PubMed ID: 25304471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
    Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
    Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
    Feng Y; Hans C; McIlwain E; Varner KJ; Lazartigues E
    PLoS One; 2012; 7(11):e48910. PubMed ID: 23155428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
    Sriramula S; Francis J
    PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.
    Haudek SB; Cheng J; Du J; Wang Y; Hermosillo-Rodriguez J; Trial J; Taffet GE; Entman ML
    J Mol Cell Cardiol; 2010 Sep; 49(3):499-507. PubMed ID: 20488188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
    Miteva K; Van Linthout S; Pappritz K; Müller I; Spillmann F; Haag M; Stachelscheid H; Ringe J; Sittinger M; Tschöpe C
    Stem Cells Transl Med; 2016 Dec; 5(12):1707-1718. PubMed ID: 27460853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction.
    Xu J; Carretero OA; Lin CX; Cavasin MA; Shesely EG; Yang JJ; Reudelhuber TL; Yang XP
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1900-7. PubMed ID: 17586619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
    Grobe JL; Mecca AP; Lingis M; Shenoy V; Bolton TA; Machado JM; Speth RC; Raizada MK; Katovich MJ
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H736-42. PubMed ID: 17098828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.
    Ebrahimian T; Sairam MR; Schiffrin EL; Touyz RM
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1481-8. PubMed ID: 18676690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
    Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.
    Wang HX; Li WJ; Hou CL; Lai S; Zhang YL; Tian C; Yang H; Du J; Li HH
    Cardiovasc Res; 2019 Jan; 115(1):83-93. PubMed ID: 29939225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6/STAT3/GPX4 signaling.
    Zhang Z; Tang J; Song J; Xie M; Liu Y; Dong Z; Liu X; Li X; Zhang M; Chen Y; Shi H; Zhong J
    Free Radic Biol Med; 2022 Mar; 181():130-142. PubMed ID: 35122997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.